趨化因子 (C-X-C基序)配體7( CXCL7)重組蛋白
Recombinant Chemokine (C-X-C motif) ligand 7 ( CXCL7)
CXCL7; PPBP; PBP; B-TG1; CTAP-III; CTAP3; CTAPIII; LA-PF4; LDGF; MDGF; NAP2; SCYB7; TC1; TC2; TGB1; THBGB1; Pro-Platelet Basic Protein; Beta-Thromboglobulin
- 編號RPA370Mu02
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位n/a
- 預(yù)測分子量-
- 實(shí)際分子量-(差異分析請參閱說明書)
- 片段與標(biāo)簽N-terminal His Tag
- 緩沖液成份磷酸鹽緩沖液（pH7.4，含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)-
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 840 ¥ 2100 ¥ 4200 ¥ 12600 ¥ 31500
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
PBS或其它。
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA370Mu01 | 趨化因子 (C-X-C基序)配體7( CXCL7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA370Mu02 | 趨化因子 (C-X-C基序)配體7( CXCL7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA370Mu01 | 趨化因子 (C-X-C基序)配體7( CXCL7)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA370Mu02 | 趨化因子 (C-X-C基序)配體7( CXCL7)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA370Mu71 | 趨化因子 (C-X-C基序)配體7( CXCL7)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| LAA370Mu81 | 趨化因子 (C-X-C基序)配體7( CXCL7)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| SEA370Mu | 趨化因子 (C-X-C基序)配體7( CXCL7)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA370Mu | 趨化因子 (C-X-C基序)配體7( CXCL7)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSA370Mu01 | 趨化因子 (C-X-C基序)配體7( CXCL7)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Clinical Hemorheology and Microcirculation | Strict heart rate control attenuates prothrombotic state and platelet activity in patients with non-valvular permanent atrial fibrillation. [Pubmed: 2347822] |
| International Journal of Pharma & Bio Sciences | STUDIES ON THE STORAGE OF POOLED PLATELETS IN NON DOP PVC CONTAINERS [Ebscohost: Source] |
| Journal of Affective Disorders | Bioprofiling of platelets in medicated patients with depression. [Pubmed:25451399] |
| Perfusion | Ex vivo simulation of cardiopulmonary bypass with human blood for hemocompatibility testing [PubMed: 26243277] |
| Physiol Behav | Differential changes in platelet reactivity induced by acute physical compared to persistent mental stress [PubMed: 26192713] |
| J Affect Disord | Bioprofiling of platelets in medicated patients with depression [PubMed: 25451399] |
| Turk Kardiyol Dern Ars | Markers of coagulation and fibrinolysis do not detect or predict the presence of left atrial appendage thrombus in patients with atrial fibrillation [Pubmed: 32147650] |
| JOURNAL OF FOOD BIOCHEMISTRY | A novel di‐peptide Met‐Glu from collagen hydrolysates inhibits platelet aggregation and thrombus formation via regulation of Gq‐mediated signaling [Pubmed: 32662128] |
| Membranes (Basel) | Endogenous Nitric Oxide-Releasing Microgel Coating Prevents Clot Formation on Oxygenator Fibers Exposed to In Vitro Blood Flow [Pubmed:35054599] |
| Vaccine | The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats [Pubmed:35183388] |
留言咨詢
